+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Medical Biomimetics Market Report and Forecast 2023-2031

  • PDF Icon


  • 147 Pages
  • April 2023
  • Region: Global
  • Expert Market Research
  • ID: 5786936
Global Medical Biomimetics Market Outlook
The value of the global medical biomimetics market was USD 34.73 billion in 2022, driven by the increasing demand for innovative medical products and technologies across the globe. The market value is anticipated to grow at a CAGR of 6.85% during the forecast period of 2023-2031 to reach a value of 63.06 billion by 2031.

Medical Biomimetics Introduction

Medical biomimetics refers to the imitation of biological systems, structures, and processes to create technologies that can be used in medicine and healthcare. These technologies are designed to replicate the natural functions of living systems, allowing for more effective and efficient treatment of diseases and injuries. The field of medical biomimetics encompasses a wide range of applications, from artificial organs and prosthetics to drug delivery systems and tissue engineering.

Medical biomimetics is based on the principle that nature has already solved many of the challenges faced by medical researchers and engineers. By studying natural biological systems and processes, scientists and engineers can identify design principles and strategies that can be used to develop new medical technologies.

The development of medical biomimetics has the potential to revolutionize healthcare by enabling the creation of advanced medical devices and treatments that are safer, more effective, and less invasive than current options. By leveraging the principles of biology and evolution, medical biomimetics offers a promising path towards the creation of truly transformative medical technologies.

Medical Biomimetics Application and Uses
Medical biomimetics is a field of science that applies principles of biology and nature to the design and development of medical devices and technologies. The applications and uses of medical biomimetics are vast and diverse, ranging from tissue engineering to drug delivery systems. Some of the common applications of medical biomimetics are:
  • Tissue engineering: Medical biomimetics is used in tissue engineering to create functional tissues and organs that can be used for transplant purposes. Biomimetic scaffolds are used to mimic the natural extracellular matrix of tissues and organs, providing a supportive structure for the growth and development of cells
  • Drug delivery systems: Biomimetic nanoparticles are used in drug delivery systems to enhance drug delivery efficiency and reduce toxicity. These nanoparticles are designed to mimic natural biological structures, such as cell membranes, to improve drug targeting and penetration
  • Implantable devices: Medical biomimetics is used in the development of implantable devices, such as prosthetics and artificial joints. These devices are designed to mimic the natural biomechanics and structure of the human body, providing a more natural and comfortable experience for patients
  • Diagnostics and imaging: Biomimetic materials are used in the development of diagnostic and imaging tools, such as biosensors and contrast agents. These materials can mimic natural biological structures, such as enzymes and proteins, to improve sensitivity and specificity of diagnostic tests
  • Wound healing: Biomimetic materials are also used in wound healing to create scaffolds that promote tissue regeneration and wound closure. These materials can mimic natural extracellular matrix components, such as collagen and elastin, to enhance tissue repair and regeneration
The global medical biomimetics market is expected to grow significantly in the coming years, driven by increasing research and development activities in the field and rising demand for advanced medical devices and technologies.

Global Medical Biomimetics Market Segmentations

Market Breakup by Product Type

  • Cardiovascular
  • Orthopedic
  • Ophthalmology
  • Dental
  • Others

Market Breakup by Application

  • Plastic Surgery
  • Wound Healing
  • Tissue Engineering
  • Others

Market Breakup by End User

  • Hospitals
  • Specialty Clinics
  • Others

Market Breakup by Region

North America

  • United States of America
  • Canada
Europe Medical
  • United Kingdom
  • Germany
  • France
  • Italy
  • Others

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • Others

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Others

Middle East and Africa

  • Saudi Arabia
  • United Arab Emirates
  • Nigeria
  • South Africa
  • Others

Global Medical Biomimetics Market Scenario

The global medical biomimetics market is projected to experience significant growth in the coming years. This is primarily due to the increasing demand for innovative medical products and technologies that can better mimic natural biological processes and structures to enhance treatment outcomes.

The rising prevalence of chronic diseases such as cardiovascular diseases, cancer, and orthopaedic disorders is expected to further drive the demand for medical biomimetics. Additionally, the increasing geriatric population, which is more susceptible to these diseases, is also expected to contribute to the market growth.

Geographically, North America is expected to dominate the market due to the presence of many established players and advanced healthcare infrastructure. However, the Asia Pacific region is expected to exhibit significant growth due to increasing investments in healthcare infrastructure and the rising demand for advanced medical devices and technologies.

Key players operating in the global medical biomimetics market include Wright Medical Group N.V., BioHorizons IPH, Inc., Biomimetics Technologies Inc., Applied Biomimetic A/S, and Veryan Medical Ltd., among others. These companies are focusing on developing and launching new products and technologies to strengthen their market position and increase their revenue share.

Key Players in the Global Medical Biomimetics Market

The report gives an in-depth analysis of the key players involved in the global medical biomimetics market. The companies included in the market are as follows:
  • Blatchford Limited
  • Vandstorm, Inc
  • Veryan Medical Limited

This product will be delivered within 5-7 business days.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Medical Biomimetics Market Overview
3.1 Global Medical Biomimetics Market Historical Value (2016-2022)
3.2 Global Medical Biomimetics Market Forecast Value (2023-2031)
4 Global Medical Biomimetics Market Landscape
4.1 Global Medical Biomimetics Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Medical Biomimetics Product Landscape
4.2.1 Analysis by Type of Biosensor
4.2.2 Analysis by Technology Used
4.2.3 Analysis by Applications
5 Global Medical Biomimetics Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Medical Biomimetics Market Segmentation
6.1 Global Medical Biomimetics Market by Product Type
6.1.1 Market Overview
6.1.2 Cardiovascular
6.1.3 Orthopedic
6.1.4 Ophthalmology
6.1.5 Dental
6.1.6 Others
6.2 Global Medical Biomimetics Market by Application
6.2.1 Market Overview
6.2.2 Plastic Surgery
6.2.3 Wound Healing
6.2.4 Tissue Engineering
6.2.5 Others
6.3 Global Medical Biomimetics Market by End User
6.3.1 Market Overview
6.3.2 Hospitals
6.3.3 Specialty Clinics
6.3.4 Others
6.4 Global Medical Biomimetics Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Medical Biomimetics Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Medical Biomimetics Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Medical Biomimetics Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.6 Australia
9.7 Others
10 Latin America Medical Biomimetics Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Medical Biomimetics Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.5 Others
17 Supplier Landscape
17.1 Blatchford Limited
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Vandstrom, Inc.
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Veryan Medical Limited
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4.1 Financial Analysis
17.4.2 Financial Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
18 Global Medical Biomimetics Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket

Companies Mentioned

  • Blatchford Limited
  • Vandstrom, Inc.
  • Veryan Medical Limited
  • Otsuka Medical Devices Group
  • Stryker
  • Abbott
  • Avinent Science and Technology
  • Syntouch Inc
  • Osteopore International Pte Ltd
  • Biomimetics Technologies Inc
  • Keystone Dental Group
  • Corneat Vision
  • Nanohive Medical LLC



Table Information